Urolift® Treatment for BPH
Benign Prostatic Hyperplasia, or BPH, is non-cancerous (benign) growth of the prostate. The enlarged prostate presses on and blocks the urethra, causing bothersome urinary symptoms.
There is a minimally invasive option for patients with BPH called UroLift® treatment. The UroLift® System opens up the blocked urethra by lifting or holding enlarged prostate tissue out of the way. There is no cutting, heating or removal of prostate tissue. The goal of treatment with the UroLift® System is to relieve symptoms so you can get back to your life and resume your daily activities almost immediately after treatment. There have been no reports of erectile dysfunction or ejaculatory dysfuntion as a result of the UroLift System treatment. Click here to view animation of the procedure.
Other Treatment Options for BPH
Currently, the most common surgery to treat BPH is Transurethral Resection of the Prostate (TURP). During this procedure, patients undergo general anesthesia, and prostate tissue is removed. Patients may suffer an uncomfortable recovery period that includes short-term problems such as bleeding, infection, erectile dysfunction, and urinary incontinence. Patients have to have a catheter that is attached to a urine bag inserted into their bladder for several days after the procedure. There can be long-term side effects after TURP such as dry orgasm (retrograde ejaculation), erectile dysfunction or incontinence (leaking of urine).
Urolift® Patient Testimonials
